Clinical Trial 43169


Tulsa, OK 74137

Study Summary:

A Phase 2, 24-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study, with a 28-week active treatment extension, to evaluate the efficacy and safety of CC-90001 in subjects with idiopathic pulmonary fibrosis.

Qualified Participants Must:

• Must be taking Esbriet for at least 8 weeks prior to screening visit.

Qualified Participants May Receive:

Free medical services, to include but not limited to: HRCT, EKG, monthly lab evaluations, doctor visits with physical and monitoring of disease (no insurance billed). Subjects will also receive $100 per visit as well as compensation for travel/lodging expenses.

Study is Available At:

Pulmonary and Sleep Center
2408 E. 81st Street, Suite #110
Tulsa, OK 74137
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.